I can tell you for sure that Novartis is well aware of and is following the progress of OPT302.
It has been on their radar since the the phase 2 trial began.
- Forums
- ASX - By Stock
- Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD
I can tell you for sure that Novartis is well aware of and is...
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
53.0¢ |
Change
-0.015(2.75%) |
Mkt cap ! $658.6M |
Open | High | Low | Value | Volume |
54.5¢ | 54.5¢ | 53.0¢ | $143.4K | 268.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 15011 | 53.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.5¢ | 21431 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 24567 | 0.530 |
11 | 82699 | 0.525 |
13 | 188561 | 0.520 |
8 | 35979 | 0.515 |
9 | 103430 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.535 | 11029 | 5 |
0.540 | 73288 | 12 |
0.545 | 41567 | 6 |
0.550 | 24380 | 6 |
0.555 | 10805 | 2 |
Last trade - 10.54am 28/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online